UGT1A1 and neutropenia: In an exploratory safety analysis, patients with the UGT1A1 *28/*28 genotype experienced higher rates of grade ≥3 neutropenia, febrile neutropenia, anemia, and diarrhea compared to those with other genotypes [45].